Classification rule mining represents a significant field of machine learning, facilitating informed decision-making through the extraction of meaningful rules from complex data. Many classification methods cannot simultaneously optimize both explainability and different performance metrics at the same time. Metaheuristic optimization-based solutions, inspired by natural phenomena, offer a potential paradigm shift in this field, enabling the development of interpretable and scalable classifiers. In contrast to classical methods, such rule extraction-based solutions are capable of classification by taking multiple purposes into consideration simultaneously. To the best of our knowledge, although there are limited studies on metaheuristic based classification, there is not any method that optimize more than three objectives while increasing the explainability and interpretability for classification task. In this study, data sets are treated as the search space and metaheuristics as the many-objective rule discovery strategy and study proposes a metaheuristic many-objective optimization-based rule extraction approach for the first time in the literature. Chaos theory is also integrated to the optimization method for performance increment and the proposed chaotic rule-based SPEA2 algorithm enables the simultaneous optimization of four different success metrics and automatic rule extraction. Another distinctive feature of the proposed algorithm is that, in contrast to classical random search methods, it can mitigate issues such as correlation and poor uniformity between candidate solutions through the use of a chaotic random search mechanism in the exploration and exploitation phases. The efficacy of the proposed method is evaluated using three distinct data sets, and its performance is demonstrated in comparison with other classical machine learning results.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11419619 | PMC |
http://dx.doi.org/10.7717/peerj-cs.2307 | DOI Listing |
J Med Internet Res
December 2024
Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé - LIMICS, Inserm, Université Sorbonne Paris-Nord, Sorbonne Université, Paris, France.
Background: Artificial intelligence (AI) applied to real-world data (RWD; eg, electronic health care records) has been identified as a potentially promising technical paradigm for the pharmacovigilance field. There are several instances of AI approaches applied to RWD; however, most studies focus on unstructured RWD (conducting natural language processing on various data sources, eg, clinical notes, social media, and blogs). Hence, it is essential to investigate how AI is currently applied to structured RWD in pharmacovigilance and how new approaches could enrich the existing methodology.
View Article and Find Full Text PDFInt J Med Inform
December 2024
Neurosurgery Department, Hamad General Hospital, Qatar; Department of Clinical Academic Sciences, College of Medicine, Qatar University, Doha, Qatar; Department of Neurological Sciences, Weill Cornell Medicine, Doha, Qatar.
Introduction: Artificial Intelligence is in the phase of health care, with transformative innovations in diagnostics, personalized treatment, and operational efficiency. While having potential, critical challenges are apparent in areas of safety, trust, security, and ethical governance. The development of these challenges is important for promoting the responsible adoption of AI technologies into healthcare systems.
View Article and Find Full Text PDFLung Cancer
December 2024
Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Background: Artificial intelligence (AI) models are emerging as promising tools to identify predictive features among data coming from health records. Their application in clinical routine is still challenging, due to technical limits and to explainability issues in this specific setting. Response to standard first-line immunotherapy (ICI) in metastatic Non-Small-Cell Lung Cancer (NSCLC) is an interesting population for machine learning (ML), since up to 30% of patients do not benefit.
View Article and Find Full Text PDFSci Rep
December 2024
SDU Health Informatics and Technology, The Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Odense, Denmark.
The increasing development of technology has led to the increase of digital data in various fields, such as medication-related texts. Sentiment Analysis (SA) in medication is essential to give clinicians insights into patients' feedback about the treatment procedure. Therefore, this study intends to develop Artificial Intelligence (AI) models to predict patients' sentiments.
View Article and Find Full Text PDFJHEP Rep
January 2025
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!